Medi Linx Laboratory and Makati Medical Center renewed their partnership in a ceremonial contract signing last March 31.
The event was led by Mr. Eiji Nakao, President and CEO of Medi Linx Laboratory, and Atty. Pilar Nenuca P. Almira, President and CEO of Makati Medical Center. Speaking during the ceremony, Mr. Nakao expressed his gratitude for the continuing engagement: “We thank you very much for the renewal of this contract. [Medi Linx Laboratory] is grateful for this wonderful opportunity to implement more achievements and improvements for Makati Medical Center and the Metro Pacific Health group of hospitals.”
Atty. Pilar Nenuca P. Almira, President and CEO of Makati Medical Center, highlighted the importance of the partnership to the hospital. “This is once again a milestone for Makati Medical Center and Medi Linx. We look forward to a wonderful and brighter future together,” said Atty. Almira. With over 50 years of recognition as the premier hospital in the country, Makati Medical Center sees this partnership as a fulfillment of its vision of continuous medical advancement and innovation.
Metro Pacific Health, the healthcare investment arm of the MVP group, is proud to count both Makati Medical Center and Medi Linx Laboratory among its hospitals and healthcare facilities, respectively. A joint venture between Metro Pacific and two premier Japanese healthcare and investment companies—LSI Medience Corporation, and Marubeni Corporation—Medi Linx leverages state-of-the-art medical technology and innovative Japanese laboratory operations. It also serves as the centralised laboratory for the 20 private hospitals and 24 outpatient centers of Metro Pacific Health in the country, delivering accurate, reliable, and top-quality clinical and diagnostic solutions nationwide.
Article by: Dana Macarilay, MPH Marketing Department
Info from: Medi Linx Laboratory Facebook account